Form 4 for KVYO Klaviyo, Inc.
Accepted 2024-03-04 00:00:00 ET · period of report 2024-02-29 · accession 0001835830-24-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-04 | 2024-02-29 | KVYO | Weisman Tony | Dir | C - Cnv Deriv | — | +33.3K | 33.3K | New | — |
| D | 2024-03-04 | 2024-02-29 | KVYO | Weisman Tony | Dir | S - Sale | $25.97 | -33.3K | 0 | -100% | -$865.7K |
| D | 2024-03-04 | 2024-02-29 | KVYO | Weisman Tony | Dir | C - Cnv Deriv | $0.00 | -33.3K | 75.0K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Series A Common Stock | 2024-02-29 | C | A | 33,333 | — | 33,333 | D | — | — | (F1) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |
| 2 | Common | Series A Common Stock | 2024-02-29 | S | D | 33,333 | $25.97 | 0 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.91 to $26.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Series B Common Stock | 2024-02-29 | C | D | 33,333 | $0.00 | 75,000 | D | — · — to — | 33,333 Series A Common Stock | (F3) Consists of (a) 66,667 shares of Series B Common Stock and (b) 8,333 unvested restricted stock units. On March 1, 2024, the remaining 8,333 RSUs vested and settled as 8,333 shares of Series B Common Stock according to the previously reported vesting schedule applicable to such grant. (F1) Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. |